The company has not filed an annual or quarterly report since its Q3 FY2020 10-Q, filed Feb 18, 2020. Its latest SEC filing is a 15-12G from May 1, 2020.
10-Q for Q3 FY2020, filed Feb 18, 2020
The sections below describe the company as of the FY2019 annual report.
Sells hemp-based health products for people and pets, and provides cannabis testing and analytics services to cannabis and hemp businesses.
10-K for FY2019, filed Jul 1, 2019We are a vertically integrated Company focused on the development of science-driven Cannabinoid therapeutics/biopharmaceuticals, and…View ↗
Applied BioSciences offers a broad selection of medical and consumer products including creams, balms, tinctures, concentrates and edibles…View ↗
The company also offers state-of-the-art testing and analytics capabilities through its majority owned subsidiary, Trace Analytics.View ↗
We currently independently or in conjunction with third parties, sell products focused on the medical, bioceutical and pet health industry.…View ↗
HerbalPet was established to create a new standard of care in the pet health industry by providing pet owners with safe, natural…View ↗
Trace Analytics, Inc., a majority owned subsidiary of the Company was acquired on January 1, 2019, and is a cannabis testing laboratory and…View ↗
Individual distributors and online channels carry its consumer and pet-health products; testing services are sold to marijuana producers and processors, dispensaries, and CBD and hemp companies.
10-K for FY2019, filed Jul 1, 2019
10-K for FY2019, filed Jul 1, 2019
Revenues. For the fiscal year ended March 31, 2019, 48% and 18% of revenue were generated from our two largest customers. For the fiscal…View ↗
10-Q for Q3 FY2020, filed Feb 18, 2020
−$1.4MView ↗
8-K, filed Mar 19, 2020
Effective March 11, 2020, the board of directors of Applied BioSciences Corp. (the “Company) terminated the employment of Raymond Urbanski…View ↗
Business pivot
The earlier report described a planned online business selling kitchen and bathroom fixtures to home builders and homeowners; the latest describes cannabinoid health products, drug development, and cannabis testing services.
10-K for FY2016, filed Jul 28, 2016 10-K for FY2019, filed Jul 1, 2019We are a vertically integrated Company focused on the development of science-driven Cannabinoid therapeutics/biopharmaceuticals, and…View ↗
Applied BioSciences offers a broad selection of medical and consumer products including creams, balms, tinctures, concentrates and edibles…View ↗
The company also offers state-of-the-art testing and analytics capabilities through its majority owned subsidiary, Trace Analytics.View ↗
Trace Analytics, Inc., a majority owned subsidiary of the Company was acquired on January 1, 2019, and is a cannabis testing laboratory and…View ↗
Loading...
